All stocks Β· MARKSANS
MP

Marksans Pharma Ltd.

MARKSANS BSE Drug Manufacturers - General Healthcare

Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Austra…

ISIN INE750C01026
Listed β€”
Quarters tracked 13
Filings 20 docs

About

Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas. Its product portfolio includes plain, enteric-coated, and film coated tablets; soft gelatin and hard capsules; oral liquids; and ointments, as well as creams and liquids. The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.

Key Metrics

as of Sep 2026
Market Cap14,825 Cr
P/E28.70
Div Yield0.28 %
Book Valueβ‚Ή66.70
52w Highβ‚Ή346.00
52w Lowβ‚Ή155.00
Face Valueβ‚Ή1.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 841.00 856.00 754.00 720.00 620.00 708.00 682.00 642.00 591.00 560.00 586.00 531.00 500.00
Expenses 628.00 661.00 594.00 576.00 520.00 582.00 543.00 495.00 462.00 450.00 453.00 417.00 398.00
Operating Profit 213.00 195.00 161.00 144.00 100.00 127.00 139.00 147.00 128.00 110.00 133.00 114.00 102.00
OPM % 25.00 23.00 21.00 20.00 16.00 18.00 20.00 23.00 22.00 20.00 23.00 21.00 20.00
Other Income 25.00 35.00 20.00 22.00 6.00 15.00 28.00 0.00 15.00 17.00 5.00 19.00 10.00
Depreciation 25.00 24.00 24.00 27.00 23.00 23.00 21.00 20.00 20.00 21.00 22.00 18.00 14.00
Interest 7.00 6.00 6.00 6.00 6.00 3.00 3.00 3.00 3.00 5.00 3.00 2.00 2.00
Profit before tax 207.00 200.00 151.00 133.00 77.00 116.00 143.00 125.00 120.00 100.00 113.00 114.00 97.00
Tax % 23.00 25.00 25.00 26.00 24.00 22.00 27.00 22.00 26.00 23.00 26.00 26.00 27.00
Net Profit 159.00 149.00 114.00 99.00 58.00 91.00 105.00 98.00 89.00 78.00 83.00 84.00 70.00
EPS in Rs 3.47 3.27 2.50 2.17 1.29 2.00 2.31 2.13 1.96 1.73 1.84 1.84 1.52

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 2,951.002,623.002,177.001,852.001,491.001,376.001,134.001,000.00913.00767.00893.00797.00
Expenses 2,350.002,090.001,719.001,513.001,232.001,037.00942.00868.00834.00722.00757.00612.00
Operating Profit 601.00533.00459.00340.00259.00340.00192.00132.0078.0045.00136.00185.00
OPM % 20.0020.0021.0018.0017.0025.0017.0013.009.006.0015.0023.00
Other Income 82.0066.0050.0059.0042.007.000.005.008.007.009.003.00
Interest 24.0012.0011.009.008.008.009.0010.0010.007.0010.0016.00
Depreciation 99.0083.0074.0052.0045.0036.0027.0023.0027.0030.0028.0016.00
Profit before tax 561.00504.00424.00338.00248.00302.00157.00104.0050.0015.00107.00156.00
Tax % 25.0024.0026.0021.0025.0021.0023.0023.0028.0024.0023.0028.00
Net Profit 420.00383.00315.00265.00187.00239.00121.0080.0036.0011.0083.00112.00
EPS in Rs 9.228.406.925.884.515.762.951.870.800.221.922.67
Dividend Payout % 10.0010.009.009.006.004.003.003.006.0023.0021.004.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 45.0045.0045.0045.0041.0041.0041.0041.0041.0041.0041.0041.00
Reserves 2,978.002,422.002,020.001,700.001,161.00846.00595.00502.00430.00392.00401.00326.00
Borrowings 343.00322.00244.00123.00111.0034.0030.00100.00118.00110.00100.00101.00
Other Liabilities 489.00451.00372.00322.00323.00307.00236.00160.00142.00209.00180.00207.00
Total Liabilities 3,856.003,240.002,681.002,190.001,636.001,228.00902.00802.00731.00752.00722.00676.00
Fixed Assets 1,044.00982.00776.00486.00428.00309.00303.00270.00279.00267.00270.00166.00
CWIP 59.0027.009.0010.003.0012.000.000.000.000.000.000.00
Investments 0.001.0027.001.000.000.000.000.000.000.000.000.00
Other Assets 2,753.002,230.001,869.001,694.001,205.00907.00599.00533.00451.00484.00452.00510.00
Total Assets 3,856.003,240.002,681.002,190.001,636.001,228.00902.00802.00731.00752.00722.00676.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 458.00207.00230.00237.0099.00179.00233.0027.0050.0014.0031.00155.00
Cash from Investing Activity -249.00-49.00-141.00-259.00-84.00-45.00-60.00-13.00-39.00-21.00-123.00-33.00
Cash from Financing Activity -71.00-65.00-69.00198.0080.00-15.00-114.00-21.003.00-3.00-58.0017.00
Net Cash Flow 138.0093.0021.00176.0094.00118.0060.00-7.0015.00-10.00-150.00138.00
Free Cash Flow 329.0035.0022.00184.0053.00133.00174.0014.0011.00-14.00-101.00118.00
CFO/OP % 99.0062.0077.0088.0066.0067.00134.0041.0073.0031.0043.00108.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 80.0075.0076.0082.0097.0072.0078.0064.0071.00118.0089.0084.00
Inventory Days 278.00270.00217.00192.00216.00248.00155.00215.00152.00151.00120.00107.00
Days Payable 96.0098.0094.0091.00102.00103.0071.0078.0054.00129.0085.0088.00
Cash Conversion Cycle 261.00247.00199.00183.00211.00217.00163.00202.00169.00140.00124.00103.00
Working Capital Days 149.00142.00129.00122.00121.00104.0087.0097.0070.0077.0059.0017.00
ROCE % 19.0020.0021.0022.0023.0038.0025.0018.0010.004.0023.0044.00

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 43.87 43.87 43.87 43.87 43.87 43.87 43.87 43.87 43.87 43.85 43.85 43.85
FIIs 17.47 16.76 8.13 16.92 19.89 22.19 21.95 21.31 18.59 15.57 15.55 15.07
DIIs 6.19 6.57 5.91 5.28 5.50 4.55 4.30 4.10 3.75 5.17 4.76 4.02
Public 32.46 32.78 42.08 33.93 30.74 29.37 29.88 30.70 33.77 35.40 35.81 37.06
No. of Shareholders 246,635 246,279 255,153 265,788 256,221 257,273 259,813 248,845 235,500 254,699 237,377 207,937

Corporate Actions

25 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Dividend 20 Aug 2026 20 Aug 2026 β€” 0.90
Dividend 01 Aug 2025 01 Aug 2025 β€” 0.80
Dividend 17 Sep 2024 17 Sep 2024 β€” 0.60
Dividend 07 Jun 2023 07 Jun 2023 β€” 0.50
Dividend 19 Aug 2022 β€” β€” 0.25
Dividend 15 Sep 2021 β€” β€” 0.25
Other 01 Jul 2021 02 Jul 2021 β€” β€” E.G.M.
Other 01 Jul 2021 02 Jul 2021 β€” β€” Extra-Ordinary General Meeting
Dividend 22 Sep 2020 β€” β€” 0.10
Dividend 19 Sep 2019 β€” β€” 0.05
Dividend 19 Sep 2018 β€” β€” 0.05
Dividend 19 Sep 2017 β€” β€” 0.05
Dividend 22 Sep 2016 β€” β€” 0.12
Dividend 23 Sep 2015 β€” β€” 0.12
Dividend 18 Sep 2014 β€” β€” 0.10
Other 19 Sep 2013 β€” β€” β€” Annual General Meeting
Other 20 Sep 2012 β€” β€” β€” Annual General Meeting
Other 22 Sep 2011 β€” β€” β€” Annual General Meeting
Other 22 Sep 2010 β€” β€” β€” Annual General Meeting
Other 17 Sep 2009 β€” β€” β€” Annual General Meeting
Other 23 Sep 2008 β€” β€” β€” Annual General Meeting
Split 11 Mar 2008 β€” 10:1 β€”
Other 19 Sep 2007 β€” β€” β€” Agm
Other 19 Sep 2006 β€” β€” β€” Agm
Other 14 Dec 2005 β€” β€” β€” Agm

Announcements

5 filings